JP5396387B2 - 心臓不整脈を治療するためのｄ−リボースの用途 - Google Patents

心臓不整脈を治療するためのｄ−リボースの用途 Download PDF

Info

Publication number
JP5396387B2
JP5396387B2 JP2010517230A JP2010517230A JP5396387B2 JP 5396387 B2 JP5396387 B2 JP 5396387B2 JP 2010517230 A JP2010517230 A JP 2010517230A JP 2010517230 A JP2010517230 A JP 2010517230A JP 5396387 B2 JP5396387 B2 JP 5396387B2
Authority
JP
Japan
Prior art keywords
ribose
atrial fibrillation
administered
grams
per day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010517230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526884A (ja
JP2010526884A5 (enExample
Inventor
ディー． ヘリック，ジェームズ
Original Assignee
バイオエナジー インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオエナジー インコーポレイティド filed Critical バイオエナジー インコーポレイティド
Publication of JP2010526884A publication Critical patent/JP2010526884A/ja
Publication of JP2010526884A5 publication Critical patent/JP2010526884A5/ja
Application granted granted Critical
Publication of JP5396387B2 publication Critical patent/JP5396387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2010517230A 2007-01-23 2008-01-23 心臓不整脈を治療するためのｄ−リボースの用途 Active JP5396387B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88194007P 2007-01-23 2007-01-23
US60/881,940 2007-01-23
PCT/US2008/000845 WO2008091618A1 (en) 2007-01-23 2008-01-23 Use of d-ribose to treat cardiac arrhythmias

Publications (3)

Publication Number Publication Date
JP2010526884A JP2010526884A (ja) 2010-08-05
JP2010526884A5 JP2010526884A5 (enExample) 2011-03-17
JP5396387B2 true JP5396387B2 (ja) 2014-01-22

Family

ID=39264528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517230A Active JP5396387B2 (ja) 2007-01-23 2008-01-23 心臓不整脈を治療するためのｄ−リボースの用途

Country Status (10)

Country Link
US (1) US8101581B2 (enExample)
EP (1) EP2120968B1 (enExample)
JP (1) JP5396387B2 (enExample)
CN (1) CN101588807B (enExample)
AT (1) ATE487485T1 (enExample)
BR (1) BRPI0806231A2 (enExample)
CA (1) CA2674717C (enExample)
DE (1) DE602008003411D1 (enExample)
ES (1) ES2352154T3 (enExample)
WO (1) WO2008091618A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
CN106138071A (zh) * 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
EP3411041A1 (en) 2016-02-01 2018-12-12 RiboCor, Inc. Use of ribose for treatment of subjects having congestive heart failure

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605644A (en) 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
DE4228215A1 (de) 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
RU2127548C1 (ru) 1996-06-26 1999-03-20 Алабовский Владимир Владимирович Способ коронарографии в эксперименте
DE19650754A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Ribose und Schlaganfall
US6159942A (en) 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6511964B2 (en) 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6159943A (en) 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
JP4927282B2 (ja) 1999-12-21 2012-05-09 バイオエナジー インコーポレイティド 血小板の保存のための組成物
CA2397707A1 (en) 2000-01-07 2001-07-19 Susan S. Percival Compositions for enhancing the immune response
US6525027B2 (en) 2000-01-20 2003-02-25 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US20030212006A1 (en) 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US8486859B2 (en) 2002-05-15 2013-07-16 Bioenergy, Inc. Use of ribose to enhance plant growth
US7687468B2 (en) 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US8759315B2 (en) 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US20040229205A1 (en) 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
US20090197818A1 (en) 2004-01-14 2009-08-06 St Cyr John A Use Of Ribose for Recovery From Anaesthesia
WO2005107768A2 (en) 2004-04-29 2005-11-17 Bioenergy, Inc. Method for improving ventilatory efficiency
US20100099630A1 (en) 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US8835396B2 (en) 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
US20090197819A1 (en) 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090232750A1 (en) 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
CN106138071A (zh) 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
US20090286750A1 (en) 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons

Also Published As

Publication number Publication date
US20080176809A1 (en) 2008-07-24
EP2120968A1 (en) 2009-11-25
ES2352154T3 (es) 2011-02-16
US8101581B2 (en) 2012-01-24
CA2674717A1 (en) 2008-07-31
WO2008091618A8 (en) 2010-04-01
ATE487485T1 (de) 2010-11-15
DE602008003411D1 (de) 2010-12-23
CA2674717C (en) 2015-10-13
BRPI0806231A2 (pt) 2011-09-06
JP2010526884A (ja) 2010-08-05
EP2120968B1 (en) 2010-11-10
WO2008091618A1 (en) 2008-07-31
CN101588807B (zh) 2012-07-04
CN101588807A (zh) 2009-11-25

Similar Documents

Publication Publication Date Title
Medi et al. Supraventricular tachycardia.
WO2009150535A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
Olley et al. The surdo-cardiac syndrome and therapeutic observations
Franga et al. Recurrent asystole resulting from high cervical spinal cord injuries
JP5396387B2 (ja) 心臓不整脈を治療するためのｄ−リボースの用途
Trippel et al. Atenolol in children with ventricular arrhythmias
Sandler et al. Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia
Bollinger et al. Treatment of the hyperkinetic heart syndrome with propranolol
Hooqenhuvze et al. Acute effects of intravenous amiodarone in patients with complex ventricular dysrhythmias
Holt et al. Intravenous amiodarone; An effective anti-arrhythmic agent
Lee et al. Effects of home-based exercise training with wireless monitoring on the left ventricular function of acute coronary syndrome patients
Van Den Branden et al. Torsade de pointes with short coupling interval
Dimich et al. Treatment of recurrent paroxysmal ventricular tachycardia
Vavricka et al. Brugada syndrome
Ariftrianto et al. His Bundle Pacing for Pacing-Induced Cardiomyopathy: Indonesian Experience and Future Prospects: A Case Report
Özkan Fascicular Left Ventricular Tachycardia Managed Medically with Diltiazem: A Case Report with Interpretation of Diagnostic Features: A Benign Form of Ventricular Tachycardia
RU2320328C2 (ru) Способ лечения персистирующей формы фибрилляции предсердий
Bayley Long-term ventricular pacing in treatment of sinoatrial block
CN118304374A (zh) 一种组合物在制备治疗心动过速和/或瓣膜反流药物中的应用
Schober Medical treatment of tachyarrhythmias.
Pitcher Sudden Cardiac Death
Canepa-Anson et al. Effects of oral pirbuterol on haemodynamics, distribution of blood flow and lactate production during treadmill exercise in patients with chronic heart failure
Northover The value of temporary electrical pacing for patients with acute myocardial infarction
Gorecka et al. Lethal Dance with Dialysis–A Case of Silent Long QT Syndrome
BUELL Sudden Cardiac Death

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130305

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130605

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130612

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130621

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130903

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131001

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131021

R150 Certificate of patent or registration of utility model

Ref document number: 5396387

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250